143 related articles for article (PubMed ID: 21524363)
21. Cost-effectiveness analysis of MRI, CE-CT and 18F-FDG PET/CT for detecting colorectal liver metastases eligible for hepatic resection.
Schnitzer ML; von Münchhausen N; Biechele G; Runtemund J; Grawe F; Geyer T; Kaiser CG; Haag F; Rübenthaler J; Froelich MF
Front Oncol; 2023; 13():1161738. PubMed ID: 37554160
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness analysis of alternative cooling strategies following cardiac arrest.
Gajarski RJ; Smitko K; Despres R; Meden J; Hutton DW
Springerplus; 2015; 4():427. PubMed ID: 26306289
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with the author-reported cost-effectiveness threshold in high-income countries: systematic review and multivariable modelling.
Boespflug N; Wittwer J; Bénard A
Eur J Health Econ; 2024 Jun; 25(4):631-639. PubMed ID: 37433889
[TBL] [Abstract][Full Text] [Related]
24. Cost-Effectiveness of Three Rounds of Mammography Breast Cancer Screening in Iranian Women.
Haghighat S; Akbari ME; Yavari P; Javanbakht M; Ghaffari S
Iran J Cancer Prev; 2016 Feb; 9(1):e5443. PubMed ID: 27366315
[TBL] [Abstract][Full Text] [Related]
25. Positron Emission Tomography (PET) and PET/CT in Thyroid Cancer: A Systematic Review and Meta-Analysis.
Schütz F; Lautenschläger C; Lorenz K; Haerting J
Eur Thyroid J; 2018 Jan; 7(1):13-20. PubMed ID: 29594049
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness analysis of diagnostic strategies for COVID-19 in Iran.
Rahmanzadeh F; Malekpour N; Faramarzi A; Yusefzadeh H
BMC Health Serv Res; 2023 Aug; 23(1):861. PubMed ID: 37580701
[TBL] [Abstract][Full Text] [Related]
27. Positron emission tomography/computed tomography for bone tumors (Review).
Muheremu A; Niu X
Oncol Lett; 2015 Feb; 9(2):522-526. PubMed ID: 25621021
[TBL] [Abstract][Full Text] [Related]
28. Genomic testing for suspected monogenic kidney disease in children and adults: A health economic evaluation.
Wu Y; Jayasinghe K; Stark Z; Quinlan C; Patel C; McCarthy H; Mallawaarachchi AC; Kerr PG; Alexander S; Mallett AJ; Goranitis I;
Genet Med; 2023 Nov; 25(11):100942. PubMed ID: 37489581
[TBL] [Abstract][Full Text] [Related]
29. Recommended 10-Year Follow-Up Strategy for Small Hepatocellular Carcinoma After Radiofrequency Ablation: A Cost-Effectiveness Evaluation.
Chen QF; Chen S; Yi JZ; Wang JL; Zhong SX; Jiang XY; Hu Y; Tan GJ; Xu J; Lyu N; Zhao M
Am J Gastroenterol; 2024 Apr; ():. PubMed ID: 38526213
[TBL] [Abstract][Full Text] [Related]
30. Increased Utilization of Positron Emission Tomography/Computed Tomography (PET/CT) Imaging and Its Economic Impact for Patients Diagnosed With Bladder Cancer.
Huo J; Chu Y; Chamie K; Smaldone MC; Boorjian SA; Baillargeon JG; Kuo YF; Kerr P; O'Malley P; Orihuela E; Tyler DS; Freedland SJ; Giordano SH; Vikram R; Kamat AM; Williams SB
Clin Genitourin Cancer; 2017 Jul; ():. PubMed ID: 28826932
[TBL] [Abstract][Full Text] [Related]
31. The social value of a QALY: raising the bar or barring the raise?
Donaldson C; Baker R; Mason H; Jones-Lee M; Lancsar E; Wildman J; Bateman I; Loomes G; Robinson A; Sugden R; Prades JL; Ryan M; Shackley P; Smith R
BMC Health Serv Res; 2011 Jan; 11():8. PubMed ID: 21223540
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the Cost-Effectiveness of Evidence-Based Interventions to Increase Female Breast and Cervical Cancer Screens: A Systematic Review.
Phillips V; Franco Montoya D; Adams EK
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539469
[TBL] [Abstract][Full Text] [Related]
33. Use and Costs of Disease Monitoring in Women With Metastatic Breast Cancer.
Accordino MK; Wright JD; Vasan S; Neugut AI; Hillyer GC; Hu JC; Hershman DL
J Clin Oncol; 2016 Aug; 34(24):2820-6. PubMed ID: 27161970
[TBL] [Abstract][Full Text] [Related]
34. Breast and Cervical Cancer Screenings: A Systematic Economic Review of Patient Navigation Services.
Chattopadhyay SK; Pillai A; Reynolds J; Jacob V; Ekwueme D; Peng Y; Cuellar AE;
Am J Prev Med; 2024 Jun; ():. PubMed ID: 38876292
[TBL] [Abstract][Full Text] [Related]
35. An assessment of the characteristics and quality of diagnostic accuracy studies for positron emission tomography conducted in Japan: a systematic review.
Nomura S; Hisashige A; Yoneoka D; Kanda M; Miyamoto K; Segawa M; Ota E; Shibuya K
EJNMMI Res; 2015; 5():6. PubMed ID: 25853012
[TBL] [Abstract][Full Text] [Related]
36. Advances in Breast PET Instrumentation.
Krishnamoorthy S; Surti S
PET Clin; 2024 Jan; 19(1):37-47. PubMed ID: 37949606
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Technology: Trends of Use and Availability in a 10-Year Period (2011-2020) among Sixteen OECD Countries.
Martella M; Lenzi J; Gianino MM
Healthcare (Basel); 2023 Jul; 11(14):. PubMed ID: 37510518
[TBL] [Abstract][Full Text] [Related]
38. To Dream the Impossible Dream: The Commitment by the Institute for Clinical and Economic Review to Rewrite the Axioms of Fundamental Measurement for Hemophilia A and Bladder Cancer Value Claims.
Langley PC
Innov Pharm; 2020; 11(4):. PubMed ID: 34007652
[TBL] [Abstract][Full Text] [Related]
39. Early stopping in clinical PET studies: How to reduce expense and exposure.
Svensson JE; Schain M; Knudsen GM; Ogden RT; Plavén-Sigray P
J Cereb Blood Flow Metab; 2021 Nov; 41(11):2805-2819. PubMed ID: 34018825
[TBL] [Abstract][Full Text] [Related]
40. Inference in functional mixed regression models with applications to Positron Emission Tomography imaging data.
Shi B; Ogden RT
Stat Med; 2021 Sep; 40(21):4640-4659. PubMed ID: 34405911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
